Christopher Viehbacher

Mr. Christopher A. Viehbacher, Chris serves as Chairman and Chief Executive Officer of Sanofi-Aventis ADS at Genzyme Polyclonals S.A.S. Mr. Viehbacher has been the Chief Executive Officer of Sanofi-Aventis S.A. (Spain) since December 1, 2008 and serves as its Managing Director. He has been the Chief Executive Officer of Sanofi (also known as Sanofi-Aventis) since December 1, 2008 and serves as its Managing Director. He serves as Chief Executive Officer of Sanofi-Aventis S A France. Mr. Viehbacher served as the Chief Executive Officer and President of Genzyme Corporation since April 2011. He served as the President of North American Pharmaceuticals for GlaxoSmithKline plc. (formerly, Wellcome GmbH) since May 2008. He served as the President of US Pharmaceuticals Division for GlaxoSmithKline PLC from January 2003 to December 2008 and served as Member of its Corporate Executive Team. Mr. Viehbacher served as the President of Pharmaceuticals Europe of GlaxoSmithKline PLC since January 2001. He served as Co-Chairman of the Portfolio Management Board at GlaxoSmithKline PLC. He joined Wellcome in 1988 as Chief Financial Accountant and served as its Finance Director since 1989. He served as a Director of Continental Europe of Glaxo Wellcome since 1999. He served as the President and Chief Executive Officer of Burroughs Wellcome Inc. from 1993 to 1995. Mr. Viehbacher joined Glaxo Wellcome France in 1995 and served as Vice President of Strategy and Integration, following a period based in London as a Member of the Co-ordination team during the Glaxo Wellcome integration. He served as General Manager of Glaxo Wellcome France, since 1996 and also served as its Chairman and Managing Director. Mr. Viehbacher served as Regional Director of Europe of Glaxo Wellcome since 2000. He served with Price Waterhouse in Germany and Canada. He served as the Chairman of Glaxo Wellcome France. He serves as Chairman of the Board of Directors at Pharmaceutical Research and Manufacturers of America. Mr. Viehbacher serves as Board Member of PhRMA. He has been a Director of Sanofi-Aventis of Sanofi-Aventis Ireland Ltd. since December 1, 2008. He served as an Executive Director of GlaxoSmithKline PLC from January 31, 2008 to September 8, 2008. He serves as the Chief Executive Officer Roundtable on Cancer, North Carolina Citizens for Business and Industry, and Chief Executive Officer Advisory Council, North Carolina GlaxoSmithKline Foundation and Triangle United Way. In 2002, he was one of two industry representatives on the G10 High Level Working Group sponsored by the European Commission to restore the competitiveness of the EU Pharmaceutical Industry. In 2003, the French Republic recognized him with its prestigious Légion d'Honneur award for his contributions to business and healthcare. He completed his training as a Chartered Accountant in Canada. Mr. Viehbacher graduated from Queen's University, Ontario, with Degree in Commerce.